1. Home
  2. LRE vs ALUR Comparison

LRE vs ALUR Comparison

Compare LRE & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lead Real Estate Co. Ltd

LRE

Lead Real Estate Co. Ltd

HOLD

Current Price

$1.29

Market Cap

20.5M

Sector

N/A

ML Signal

HOLD

ALUR

Allurion Technologies Inc.

HOLD

Current Price

$1.31

Market Cap

18.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LRE
ALUR
Founded
2001
2009
Country
Japan
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
20.5M
18.9M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
LRE
ALUR
Price
$1.29
$1.31
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$9.25
AVG Volume (30 Days)
7.7K
58.2K
Earning Date
01-01-0001
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
32.27
N/A
EPS
0.43
N/A
Revenue
$130,601,512.00
$17,208,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$15.47
P/E Ratio
$3.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$1.02
52 Week High
$2.97
$16.81

Technical Indicators

Market Signals
Indicator
LRE
ALUR
Relative Strength Index (RSI) 43.25 35.76
Support Level $1.26 $1.29
Resistance Level $1.45 $1.48
Average True Range (ATR) 0.06 0.11
MACD -0.00 -0.02
Stochastic Oscillator 16.22 9.18

Price Performance

Historical Comparison
LRE
ALUR

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Share on Social Networks: